NFKB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.286190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.555600E-02
Normal-vs-Stage2
1.706960E-01
Normal-vs-Stage3
2.200000E-02
Normal-vs-Stage4
7.890000E-01
Stage1-vs-Stage2
7.698400E-01
Stage1-vs-Stage3
2.945600E-01
Stage1-vs-Stage4
1.613240E-01
Stage2-vs-Stage3
2.483600E-01
Stage2-vs-Stage4
2.112200E-01
Stage3-vs-Stage4
6.898200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.176970E-01
Normal-vs-AfricanAmerican
5.322200E-01
Normal-vs-Asian
2.089900E-02
Caucasian-vs-AfricanAmerican
3.391800E-01
Caucasian-vs-Asian
1.476050E-01
AfricanAmerican-vs-Asian
1.143980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.192760E-01
Normal-vs-Female
1.537010E-01
Male-vs-Female
4.927200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.258800E-01
Normal-vs-Age(41-60Yrs)
3.650800E-01
Normal-vs-Age(61-80Yrs)
7.318400E-02
Normal-vs-Age(81-100Yrs)
1.139610E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.238000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.632200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.631200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.975800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.327800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.303400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.845600E-02
Normal-vs-Daily Drinker
1.968420E-02
Normal-vs-Weekly Drinker
4.830300E-02
Normal-vs-Occasional Drinker
9.255600E-02
Normal-vs-Social Drinker
4.593800E-01
Non Drinker-vs-Daily Drinker
5.069400E-01
Non Drinker-vs-Weekly Drinker
8.142600E-01
Non Drinker-vs-Occasional Drinker
4.819000E-01
Non Drinker-vs-Social Drinker
1.232590E-01
Daily Drinker-vs-Weekly Drinker
7.240200E-01
Daily Drinker-vs-Occasional Drinker
1.534570E-01
Daily Drinker-vs-Social Drinker
3.572000E-02
Weekly Drinker-vs-Occasional Drinker
3.620200E-01
Weekly Drinker-vs-Social Drinker
1.235790E-01
Occasional Drinker-vs-Social Drinker
3.393000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.110000E-01
Normal-vs-Grade 2
2.765500E-02
Normal-vs-Grade 3
4.201800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.194600E-01
Grade 1-vs-Grade 3
2.225400E-01
Grade 1-vs-Grade 4
3.110000E-01
Grade 2-vs-Grade 3
5.795000E-01
Grade 2-vs-Grade 4
2.765500E-02
Grade 3-vs-Grade 4
4.201800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.108000E-01
Normal-vs-NonDiabetic
6.522400E-02
Diabetic-vs-NonDiabetic
3.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.382000E-01
Normal-vs-NoPancreatitis
9.238100E-02
Pancreatitis-vs-NoPancreatitis
3.709400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.061650E-01
Normal-vs-N1
1.598810E-01
N0-vs-N1
2.754000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.716000E-02
Normal-vs-TP53-NonMutant
8.517800E-02
TP53-Mutant-vs-TP53-NonMutant
6.961600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
